Scarica l'app Stockscreener
63.20
0.94%
-0.60
Pre-mercato:
63.88
0.68
+1.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché AZN Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$63.80
Aprire:
$63.89
Volume 24 ore:
6.22M
Relative Volume:
1.24
Capitalizzazione di mercato:
$197.66B
Reddito:
$51.21B
Utile/perdita netta:
$6.50B
Rapporto P/E:
31.92
EPS:
1.98
Flusso di cassa netto:
$6.76B
1 W Prestazione:
-3.20%
1M Prestazione:
-19.24%
6M Prestazione:
-18.04%
1 anno Prestazione:
-0.92%
Intervallo 1D:
$62.88
$63.93
Intervallo di 1 settimana:
$62.75
$65.98
Portata 52W:
$60.47
$87.67
Astrazeneca PLC Stock (AZN) Company Profile
Nome
Astrazeneca PLC
Settore
Industria
Telefono
44 20 3749 5000
Indirizzo
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Confronta AZN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| AZN | 63.20 | 197.66B | 51.21B | 6.50B | 6.76B | 1.98 |
Astrazeneca PLC Stock (AZN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-13 | Downgrade | Deutsche Bank | Hold → Sell |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-04-16 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2024-02-08 | Downgrade | Deutsche Bank | Hold → Sell |
| 2024-01-23 | Iniziato | Morgan Stanley | Overweight |
| 2024-01-16 | Ripresa | UBS | Sell |
| 2024-01-03 | Downgrade | Jefferies | Buy → Hold |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-09-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-07-12 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-05 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-04-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | Iniziato | BMO Capital Markets | Outperform |
| 2022-09-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | Aggiornamento | Argus | Hold → Buy |
| 2022-06-14 | Downgrade | UBS | Buy → Neutral |
| 2022-02-11 | Aggiornamento | DZ Bank | Sell → Hold |
| 2021-12-07 | Downgrade | Jefferies | Buy → Hold |
| 2021-08-12 | Ripresa | JP Morgan | Overweight |
| 2021-04-12 | Downgrade | Argus | Buy → Hold |
| 2021-03-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-25 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-15 | Iniziato | Deutsche Bank | Buy |
| 2020-12-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | Aggiornamento | UBS | Sell → Neutral |
| 2020-11-11 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2020-09-29 | Iniziato | Berenberg | Buy |
| 2019-11-22 | Iniziato | SVB Leerink | Outperform |
| 2019-10-25 | Aggiornamento | Liberum | Hold → Buy |
| 2019-04-02 | Downgrade | UBS | Neutral → Sell |
| 2019-02-05 | Iniziato | Exane BNP Paribas | Outperform |
| 2019-01-25 | Aggiornamento | Shore Capital | Hold → Buy |
| 2018-12-11 | Ripresa | Jefferies | Hold |
| 2018-10-09 | Iniziato | Guggenheim | Buy |
| 2018-08-16 | Downgrade | Jefferies | Buy → Hold |
| 2018-03-19 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-02-06 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-05 | Reiterato | Bernstein | Outperform |
| 2018-01-18 | Reiterato | Leerink Partners | Mkt Perform |
| 2017-12-29 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
Mostra tutto
Astrazeneca PLC Borsa (AZN) Ultime notizie
3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now - The Motley Fool
astrazeneca non-executive director buys company shares By Investing.com - Investing.com Nigeria
How AstraZeneca Ruling Could Change Dosage Patent Claims - Law360
Claim Spotter: AstraZeneca calls in Fieldfisher over HQ fire - The Lawyer
AstraZeneca PLC ADR underperforms Wednesday when compared to competitors - MarketWatch
AstraZeneca, United Utilities, AFC Energy: What brokers said today, - Proactive Investors UK
AstraZeneca raised to neutral at UBS despite China headwinds - MSN
AstraZeneca stock raised to neutral at UBS (AZN:NASDAQ) - Seeking Alpha
This AstraZeneca Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga
AstraZeneca Says Current, Former Executives Involved in China Probe - MSN
Jennison Associates LLC Sells 2,059,108 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Howe & Rusling Inc. Sells 29,784 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time - Pharmaceutical Technology
AstraZeneca Loses Lone Bear as UBS Upgrades After China-Led Rout - Bloomberg
AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Boosted by Pathstone Holdings LLC - MarketBeat
AstraZeneca upgraded by leading investment bank, but challenges remainhere's why - Proactive Investors UK
AstraZeneca: UBS is no longer a seller - Marketscreener.com
AstraZeneca hits out at NICE block to breast cancer drug - Proactive Investors UK
AstraZeneca’s Andexxa Could Be Headed For Withdrawal After US FDA’s Negative Advisory Committee Preview - Citeline News & Insights
AstraZeneca PLC ADR rises Tuesday, still underperforms market - MarketWatch
AstraZeneca rises Tuesday, outperforms market - MarketWatch
Trump-induced Pharma fears shouldn't be long-lived - Marketscreener.com
AstraZeneca (AZN) Faces Legal Scrutiny Amid Chinese Investigatio - GuruFocus.com
New Millennium Group LLC Sells 28,749 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC - Yahoo Finance
Prospera Financial Services Inc Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Leerink Partnrs Cuts Earnings Estimates for AstraZeneca - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat
CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC - Pharmaceutical Technology
Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca - Korea Economic Daily
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLCAZN - PR Newswire
Stocks in news: Waaree Energies, GMR Infra, AstraZeneca, Indus Towers, Ashoka Buildcon & ITI - Business Today
AstraZeneca Tries Plan B For Dato-DXd After Regulator Feedback - Citeline News & Insights
AstraZeneca PLC ADR rises Monday, still underperforms market - MarketWatch
AstraZeneca falls Monday, underperforms market - MarketWatch
Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership - Pharmaceutical Technology
Astrazeneca exercises option for type 1 diabetes Treg cell therapy program with Quell - BioWorld Online
Is AstraZeneca PLC (AZN) the Best Immunotherapy Stock to Buy Now? - Insider Monkey
Is AstraZeneca PLC (AZN) A Cheap NASDAQ Stock To Invest In Now? - Insider Monkey
AstraZeneca's Tagrisso recommended for EU approval - ShareCast
AstraZeneca: new positive CHMP opinion for Tagrisso - Marketscreener.com
AstraZeneca's cell lung cancer drug sent for EU approval - baha news
Natixis Advisors LLC Acquires 117,162 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Sees Large Increase in Short Interest - MarketBeat
AstraZeneca PLC (LON:AZN) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
AstraZeneca PLC ADR outperforms competitors despite losses on the day - MarketWatch
FIVE at FIVE: GSK, AstraZeneca plummet; LandSec profits; Economy stalls; FTSE 100 meanders; TT snubs Volex - Proactive Investors USA
AstraZeneca PLC (LON:AZN) Insider Pascal Soriot Purchases 20,000 Shares - MarketBeat
Trump anti-vax health appointment wipes £7bn from AstraZeneca and GSK - Proactive Investors USA
FTSE 100 Live: Index regains; GSK, AstraZeneca weighUK economic growth slows - Proactive Investors UK
Astrazeneca PLC Azioni (AZN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):